Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,017.97 -34.02 (-3.23%)
Official Closing Price Updated: 7:00 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,094,287
Open 1,044.62
Bid (Size) 1,019.00 (3,280)
Ask (Size) 1,020.00 (40)
Prev. Close 1,051.99
Today's Range 1,013.00 - 1,056.20
52wk Range 623.78 - 1,133.95
Shares Outstanding 956,580,893
Dividend Yield 0.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Best Healthcare Stock to Invest $1,000 in Right Now ↗
There's nothing generic about this drugmaker's recent performance and continued prospects. 
Via The Motley Fool
News headline image
Buying This 1 Pharmaceutical Stock Today Could Make You a Multimillionaire Retiree ↗
This stock looks unstoppable right now. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-5.8%
-5.8%
1 Month
-2.5%
-2.5%
3 Month
-3.8%
-3.8%
6 Month
+38.5%
+38.5%
1 Year
+9.5%
+9.5%

More News

Read More
News headline image
Why I'm Not Worried About Novo Nordisk Stock ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Up Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock? ↗
Via The Motley Fool
News headline image
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Great Divergence: AI Supremacy Masks a Hidden Bear Market in Healthcare and Industrials
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The 7,800 Frontier: Morgan Stanley Flips the Script with Bullish S&P 500 Forecast
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
Via MarketMinute
Topics Artificial Intelligence ETFs
News headline image
S&P 500 Crosses Historic 7,000 Milestone: Technical and Psychological Significance of the Breakout
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
Via Barchart.com
Topics Stocks
News headline image
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
OPKO Health (OPK) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
The Great Recalibration: Investors Pivot from Silicon Dreams to Industrial Reality
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
Forget Altimmune: This Proven Obesity‑Drug Giant Is the Better Weight‑Loss Play ↗
Via The Motley Fool
News headline image
Why Shares of Novo Nordisk Stock Sank (Again) This Week ↗
Via The Motley Fool
News headline image
Viking Therapeutics: The High-Stakes Weight Loss Contender ↗
Via MarketBeat
News headline image
Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 ↗
Via Benzinga
News headline image
The Darwinian Transition: AI Monetization and Metabolic Mastery Define the Market’s New Frontier
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
Alphabet Inc. (GOOGL) Deep Dive: Navigating the Agentic Era and the $180 Billion AI Bet
Via Finterra
Topics Artificial Intelligence Initial Public Offering Workforce
News headline image
Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore ↗
Via The Motley Fool
News headline image
Eli Lilly’s Diabetes Pill Outperforms Oral Semaglutide in Phase 3 Trial ↗
Via Stocktwits
News headline image
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies ↗
Via The Motley Fool
Topics Stocks

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,017.97
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 03/02/26 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 973.77B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 974B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>